Beijing Minhai Biotechnology Coltd Is A Modern Biotechnology Enterprise Specialized In Vaccine R&Dproduction And Distributionminhai S Mission Is To Provide Safestable And Affordable Vaccinesincrease Immunization Coveragereduce The Incidence Of Infectious Disease And Mortalityprotect Human Healthminhai Was Founded In June 2004With A Registered Capital Of 200 Million Rmbat No 35Simiao Roadbio Medicine Industry Park In Daxing Districtbeijingwhich Has A Leading R&D Center And A Modern Vaccine Manufacturing Site Composed Of Over 60 000 M2 Gmp Compliant Workshopsequipped With Advanced Large Scale Bacteria Vaccine Production Line And Virus Vaccine Production Lineuntil 2015There Are Three Commercialized Vaccine Products In Chinaincluding Hib Conjugate Vaccinemr Vaccine And Dtap Hib Vaccinedtap Hib Vaccinewhich Is Independently Developed By Minhaiis The First Domestic Quatri Valent Vaccine There Are Over 20 Vaccines In Minhai S Pipelinefrom Pre Clinical Trial To Nda Including Pneumococcal Conjugate Vaccinehdcv Rabies Vaccinesabin Ipv And Meningitis Conjugate Vaccine Etc In The Meantime Of Developing Novel Vaccinesminhai Initiated International Registration And Accelerated The Process Of Exportfrom 2013Minhai Has Started The Registration Of Three Marketed Products In More Than 10 Countries Including Indiarussia And The Philippinesand Initiated Who Prequalification Preparationminhai Is Enlarging Multi Anglemulti Level International Collaborationand Extensively Promote Globalization Strategy Minhai Is Collaborating And Competing With World Class Vaccine Enterprisesworking Hard To Share Minhai S Safestable And Affordable Vaccines With All Human Beings Around The World
Germany
